IP Library › Granted Patent US 9,938,557
Granted Patent B2
US 9,938,557 · App. 13/823,338 · Granted Apr 10, 2018

Red blood cell dynamics for administering treatment for iron-deficiency anemia

Inventor: John M. Higgins (Cambridge, MA)
Assignee: The General Hospital Corporation
C12Q1/02G01N33/6893G01N33/721G01N33/80G01N33/94G01N2800/06G01N2800/22G01N2800/224
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,557
App. No.
13/823,338
Granted
Apr 10, 2018
Kind
B2
Abstract

Methods for identifying patients with anemia, distinguishing thalassemia-trait anemia from iron-deficiency anemia, and identifying pre-anemic patients several weeks before anemia becomes clinically detectable. Also, methods for detecting blood doping in athletes and for optimizing therapy with erythropoiesis stimulating agents or iron supplementation. Computer-readable storage devices and systems, e.g., for use in the described methods.

Claims (39)

1. A method comprising:

measuring, using a hemanalyzer, a complete blood count (CBC) of a sample of red blood cells from a subject, a volume and a hemoglobin content of each red blood cell in the sample, and a mean corpuscular hemoglobin concentration (MCHC) of a population of the red blood cells of the sample;

identifying that the subject does not have iron deficiency anemia (IDA) based on the CBC;

transforming, using a suitably programmed computing device, the volume and the hemoglobin content of each red blood cell into an index by projecting the volume and the hemoglobin content of each red blood cell onto an MCHC line defined by the MCHC;

determining, using the computing device, a sample percentage of the red blood cells is above a reference percentage, wherein, in a portion of the red blood cells corresponding to the sample percentage, the index of each red blood cell falls below a threshold location on the MCHC line, the threshold location corresponding to a percentage of a mean of the indexes of the red blood cells; and

administering treatment for IDA to the subject who does not have IDA based on determining that the sample percentage is above the reference percentage.

2. The method of claim 1 , wherein the threshold location corresponds to 70%, 75%, 80%, 85%, 90%, or 95% of the mean of the indexes.

3. The method of claim 1 , wherein the reference percentage is about 10%, 11%, 12%, 13%, 14%, or 15%.

4. The method of claim 1 , wherein the sample comprises whole blood from the subject.

5. The method of claim 1 , wherein projecting the volume and the hemoglobin content of each red blood cell onto the MCHC line comprises performing a projection operation defined by

u

=

v

·

cos

⁢

⁢

θ

-

h

·

sin

⁢

⁢

θ

θ

=

-

tan

-

1

⁡

(

h

_

v

_

)

for each red blood cell, wherein v is a mean cell volume measured in the CBC, h is a mean cell hemoglobin content measured in the CBC, v is a volume of a red blood cell, h is a hemoglobin content of the red blood cell, and u is an index of a projection of the red blood cell onto the MCHC line.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: HIGGINS, JOHN M.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 030499/0634 →
Continuity (2)
Provisional Application 61383357 · Sep 16, 2010
Related Publication 20130236566A1 · Sep 12, 2013